Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

GATIFLOXACIN Drug Profile

« Back to Dashboard

Which patents cover Gatifloxacin, and when can generic versions of Gatifloxacin launch?

Gatifloxacin is a drug marketed by Sandoz Inc, Lupin Ltd, Apotex Inc, and Hi-tech Pharma Co. and is included in four NDAs.

The generic ingredient in GATIFLOXACIN is gatifloxacin. There are sixteen drug master file entries for this compound. Seven suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the gatifloxacin profile page.

Summary for Tradename: GATIFLOXACIN

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list4
Bulk Api Vendors: see list80
Clinical Trials: see list11
Patent Applications: see list3,518
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GATIFLOXACIN at DailyMed

Pharmacology for Tradename: GATIFLOXACIN

Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
GATIFLOXACIN
gatifloxacin
SOLUTION/DROPS;OPHTHALMIC204227-001Jul 11, 2016ATRXNoNo► Subscribe► Subscribe
Hi-tech Pharma Co
GATIFLOXACIN
gatifloxacin
SOLUTION/DROPS;OPHTHALMIC203189-001Sep 3, 2014ATRXNoNo► Subscribe► Subscribe
Lupin Ltd
GATIFLOXACIN
gatifloxacin
SOLUTION/DROPS;OPHTHALMIC202653-001Aug 28, 2013ATRXNoNo► Subscribe► Subscribe
Apotex Inc
GATIFLOXACIN
gatifloxacin
SOLUTION/DROPS;OPHTHALMIC079084-001Aug 19, 2011DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot